FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

NCT06865664 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

NIH

Sponsor class

Conditions

Rhabdomyosarcoma

Interventions

DRUG: fludarabine
DRUG: cyclophosphamide
DRUG: cetuximab
BIOLOGICAL: FGFR4-CAR T Cells

Sponsor

National Cancer Institute (NCI)